First Blood-Based Test Cleared For Alzheimer’s Boosts Anti-Amyloid Drugs

Early Diagnosis Key To Treating Mild Cognitive Impairment

Anti-amyloid drug prescribers can now diagnose Alzheimer's pathology with a blood test rather than a PET scan or CSF test (Shutterstock)

More from Strategy

More from Scrip